Physician profile
Donald Paoletti
NPI 1437255361
$366.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $34.06 · 2022: $12.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $74.04 | 2019 | |
| Adlon Therapeutics L.P. | $58.05 | 2019-2020 | |
| Bausch Health US, LLC | $53.05 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $42.09 | 2019 | |
| Allergan, INC. | $36.52 | 2019 | |
| Shire North American Group INC | $24.76 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.58 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.17 | 2019 | |
| Tris Pharma INC | $11.37 | 2019 | |
| Neuronetics, INC. | $11.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Paoletti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.